Skip to content

Net margin at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-7,965.8%-10,750pp
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-32,753.6%-35,519pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-284.2%+937pp
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
-612%+602pp
Alumis Inc. logo
Alumis Inc.ALMS
-2,825.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp

Other financials

Income statement

See full
Revenue$900.0K+12.5%
Operating income-$47.9M-80.1%
Net income-$47.6M-75.6%
EPS (diluted)-$0.11+57.7%

Balance sheet

See full
Cash & equivalents$229.2M+1,668%
Total debt$6.1M-15.7%
Total equity$207.9M+7,069%
Total assets$266.4M+427%

Cash flow

See full
Operating cash flow-$49.1M-149%
CapEx$400.0K
Free cash flow-$49.5M-151%

Valuation

See full
Market cap$923.31M+259%
Enterprise value$700.21M+179%
P/S159.6×+87.1×

Profitability

See full
Operating margin-2,910.4%-265pp
FCF margin-2,619.5%+69.9pp

Returns & leverage

See full
Return on equity-158.9%-26.4pp
Debt / equity-2.5×
Current ratio4.8×+4.0×

Where this comes from

Calculated from DBV Technologies’s reported figures.

Based on trailing twelve months.

The official record: DBV Technologies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DBV Technologies's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DBV Technologies's net margin?
DBV Technologies (DBVT) reported net margin of -2,895.4% in Q1 2026.
How has DBV Technologies's net margin changed year-over-year?
DBV Technologies's net margin increased by 9.7% year-over-year, from -3,207.5% to -2,895.4%.
What is the long-term trend for DBV Technologies's net margin?
Over 3 years (2021 to 2025), DBV Technologies's net margin has grown at a 14.7% compound annual growth rate (CAGR), from -1,713.5% to -2,585.6%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.